32
Participants
Start Date
September 24, 2021
Primary Completion Date
January 29, 2024
Study Completion Date
January 29, 2024
CC-97489
Specified dose on specified days
[18F]T-401
Specified dose on specified days
[11C]MK-3168
Specified dose on specified days
Local Institution - 001, Leuven
Lead Sponsor
Celgene
INDUSTRY